Search Results 11-20 of 15059 for Tamoxifen

  1. New international practice guidelines for tamoxifen treatment based on CYP2D6 genotype - Mayo Clinic News Network

    CYP2D6 genotype is an inherited factor that alters the metabolism of tamoxifen. “The goal of the CPIC Guideline for CYP2D6 and tamoxifen therapy is to provide ...

  2. Z-endoxifen shows promise as new treatment for common breast cancer type - Mayo Clinic News Network

    – Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer in women with metastatic ...

  3. Low-Dose Tamoxifen Citrate In Reducing Breast Cancer Risk In Radiation-Induced Cancer Survivors - Mayo Clinic

    About this study. Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate may fight breast cancer by blocking the use ...

  4. Letrozole After Tamoxifen in Treating Women With Breast Cancer - Mayo Clinic

    PURPOSE: This randomized phase III trial is studying letrozole to see how well it works in treating women with breast cancer who have received tamoxifen for at ...

  5. A Study Of Tamoxifen Citrate For Treating Patients With Metastatic Or Recurrent Breast Cancer - Mayo Clinic

    Hormone therapy using tamoxifen citrate may fight cancer by blocking the use of estrogen by tumor cells. Participation eligibility. Participant eligibility ...

  6. A Study Of Low Dose Tamoxifen For Patients At High Risk For Breast Cancer - Mayo Clinic

    The purpose of this study is to determine if counseling patients about low dose tamoxifen will influence the decision to take (or not take) preventive therapy ...

  7. Endoxifen Shows Promise as Breast Cancer Treatment - Mayo Clinic News Network

    ... tamoxifen. We have seen evidence for tumor regression in patients who had failed standard hormonal therapies including aromatase inhibitors, fulvestrant and ...

  8. Like tamoxifen, raloxifene works by blocking estrogen's effects in the breast and other tissues. Unlike tamoxifen, raloxifene doesn't exert estrogen-like ...

  9. Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Mayo Clinic

    The purpose of this study is to analyze breast tissue changes after a short course of Tamoxifen (Tam). Participation eligibility. Participant eligibility ...

  10. Estrogen blocker therapy for breast cancer

    It's often used to lower the risk of cancer recurrence after treatment for early-stage breast cancer. It's typically taken for 5 to 10 years. Tamoxifen also may ...